Discover the full management transaction log of Kairos Pharma, LTD., a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €10m. The latest transaction was filed on 30 December 2025 (Attribution). Among the most active insiders: Bhowmick Neil. All data is accessible without an account.
9
Insider Decl.
0
Thresholds
€9,315
3 ops.
Buy Volume
·
0 ops.
Sell Volume
49Σ signal
Buys €9,315· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.